BSECompany Update6 Oct 2026
Valiant Organics Ltd
Please find our intimation in captioned subject
Valiant Organics Ltd has issued a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming that all securities of the company are held in dematerialized form and no requests for dematerialization, mutilation, or cancellation of securities were received during the quarter ended September 30, 2026.
BSECompany UpdateRegulatory1 Oct 2026
Valiant Organics Ltd
Please find our intimation in captioned subject
Valiant Organics Ltd has received a Rectification Order under Section 154 of the Income-tax Act, 1961, for Assessment Year 2015-16, in the name of erstwhile Amarjyot Chemical Limited. The order rectifies a mistake apparent from the record and determines a net amount payable of Rs. 22,15,080/-.
BSECompany UpdateMgmt Change30 Sept 2026
Valiant Organics Ltd
Please find our intimation in captioned subject
Valiant Organics Ltd has announced the re-appointment of Shri Nemin M. Savadia, Shri Santosh S. Vora, and Shri Sathiababu K. Kallada as Directors, with Kallada being re-appointed as Managing Director for a term of 3 years.
BSEAGM/EGMResults30 Sept 2026
Valiant Organics Ltd
Please find E-voting and Scrutinizer report of 21st Annual General Meeting of the Company
Valiant Organics Ltd has announced the E-voting and Scrutinizer report of its 21st Annual General Meeting, which was held on September 29, 2026. The report details the voting results for various resolutions, including the adoption of audited financial statements and the appointment of directors.
BSECompany Update29 Sept 2026
Valiant Organics Ltd
Please find enclosed herewith presentation made to the shareholders at 21st Annual General Meeting of the Company.
Valiant Organics Ltd presented its annual general meeting (AGM) presentation to shareholders, highlighting its manufacturing capabilities, diversified product range, and strategic locations.
BSEAGM/EGMResults29 Sept 2026
Valiant Organics Ltd
Please find enclosed the Proceedings of the 21st Annual General Meeting of the Company held on today i.e. Tuesday, September 29, 2026.
Valiant Organics Ltd has held its 21st Annual General Meeting (AGM) on September 29, 2026, through Video Conferencing and Other Audio-Visual Means (VC/OAVM). The meeting was attended by 51 members, and the company reported revenue from operations for FY 2025-26 at Rs.738.38 crore, EBITDA at Rs.100.80 crore, and Profit After Tax of Rs.34.36 crore.
BSEInsider Trading / SASTinsider_trading28 Sept 2026
Valiant Organics Ltd
Please find our intimation in the captioned subject
Valiant Organics Ltd has announced the closure of its trading window for all directors, promoters, and connected persons from October 1, 2026, until 48 hours after the declaration of its financial results for the quarter and half-year ended September 30, 2026, in accordance with SEBI regulations.
BSECompany UpdateResults2 Sept 2026
Valiant Organics Ltd
Newspaper Publication of pre-dispatch of Notice of 21st Annual General Meeting of the Company
Valiant Organics Ltd announces the newspaper publication of the pre-dispatch of notice for its 21st Annual General Meeting, scheduled to be held on September 29, 2026, through Video Conferencing/Other Audio Visual Means.
BSECompany UpdateResults21 Aug 2026
Valiant Organics Ltd
Please find our intimation in captioned subject.
Valiant Organics Ltd has announced its Q1-FY27 earnings presentation, highlighting its diversified client base, manufacturing units, and production capacity. The company has a strong presence in the chlorophenol derivatives market and is one of the largest domestic manufacturers of ortho anisidine and para anisidine. Valiant Organics has a market capitalization of INR ~ 7,545.68 Mn as on 30th June 2026.
BSECompany UpdateResults14 Aug 2026
Valiant Organics Ltd
Publication of financial results for the quarter ended June 30, 2026 and Notice to shareholders for the intimation of transfer of unclaimed/unpaid dividend to IEPF.
Valiant Organics Ltd has published its financial results for the quarter ended June 30, 2026, and has also issued a notice to shareholders regarding the transfer of unclaimed dividend to the Investor Education Protection Fund (IEPF).
BSECompany UpdateResults14 Aug 2026
Valiant Organics Ltd
Please find our intimation in the captioned subject
Valiant Organics Ltd has published its unaudited financial results for the quarter ended June 30, 2026, and has also notified shareholders about the transfer of unclaimed dividend to the Investor Education Protection Fund (IEPF).
BSECompany Updateemployee_stock_option12 Aug 2026
Valiant Organics Ltd
Please find our intimation in the captioned subject
Valiant Organics Ltd has granted 18,000 employee stock options to an eligible employee at an exercise price of Rs. 10 per option, subject to SEBI regulations.
BSECompany UpdateMgmt Change12 Aug 2026
Valiant Organics Ltd
Intimation of the new corporate office
Valiant Organics Ltd has announced the shifting of its Corporate Office to 701-A, Tower-B, Embassy 247 Park, Gandhi Nagar, Vikhroli (West), Mumbai – 400083, Maharashtra, from August 12, 2026. The company has also announced the re-appointment of Shri Sathiababu K. Kallada as the Managing Director for a term of 3 years, subject to shareholder approval.
BSECompany UpdateMgmt Change12 Aug 2026
Valiant Organics Ltd
Change in the Registered Office Address of the Company, subject to approval of the shareholders of the Company in the ensuing AGM.
Valiant Organics Ltd has announced a change in its registered office address, subject to shareholder approval, and reappointment of its Managing Director, Sathiababu K. Kallada, for a term of 3 years. The company has also published its unaudited standalone financial results for the quarter ended June 30, 2026.
BSECompany UpdateMgmt Change12 Aug 2026
Valiant Organics Ltd
Re-appointment of a Managing Director, subject to approval of the shareholders of the Company in the ensuing AGM.
Valiant Organics Ltd has announced the re-appointment of Sathiababu K. Kallada as Managing Director for a term of 3 years, subject to shareholder approval. The company has also announced its unaudited standalone financial results for the quarter ended June 30, 2026, and has shifted its registered office to a new location.
BSEResultResults12 Aug 2026
Valiant Organics Ltd
Please find our intimation in the captioned subject
Valiant Organics Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has also re-appointed Sathiababu K. Kallada as Managing Director for a term of 3 years. The company has also shifted its registered office and corporate office to new locations.
BSEBoard MeetingResults12 Aug 2026
Valiant Organics Ltd
Approval of the unaudited financial results for the quarter ended June 30, 2026 and other matters
Valiant Organics Ltd has approved its unaudited financial results for the quarter ended June 30, 2026, and other matters, including the re-appointment of its Managing Director and the shifting of its Registered Office.
BSEBoard MeetingResults7 Aug 2026
Valiant Organics Ltd
Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve financial results for the ....
Valiant Organics Ltd has scheduled a Board Meeting on August 12, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
BSECompany Update▲ PositiveRating Change6 Aug 2026
Valiant Organics Ltd
Please find our intimation in the captioned subject
Valiant Organics Ltd has announced that CRISIL Ratings Limited has reaffirmed the credit ratings assigned to the company's bank facilities, with a revised outlook from 'Negative' to 'Stable'. The long-term rating remains at Crisil A-/ Stable, while the short-term rating is Crisil A2+.
BSECompany Update▲ PositiveRating Change6 Aug 2026
Valiant Organics Ltd
Please find attached our intimation in the captioned subject
Valiant Organics Ltd has received a reaffirmation of its credit ratings from CRISIL Ratings Limited, with a revised outlook from 'Negative' to 'Stable'. The company's long-term rating has been reaffirmed at 'Crisil A-', while the short-term rating remains 'Crisil A2+'.